Therapeutic implications of non-genomic glucocorticoid activity
- 1 July 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 356 (9224) , 87-89
- https://doi.org/10.1016/s0140-6736(00)02463-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchyBiochemical Pharmacology, 1999
- Anti-inflammatory Actions of Glucocorticoids: Molecular MechanismsClinical Science, 1998
- A new hypothesis of modular glucocorticoid actions: Steroid treatment of rheumatic diseases revisitedArthritis & Rheumatism, 1998
- SPECIFIC, NONGENOMIC ACTIONS OF STEROID HORMONESAnnual Review of Physiology, 1997
- Methylprednisolone inhibits uptake of Ca2+ and Na+ ions into concanavalin A-stimulated thymocytesBiochemical Journal, 1997
- A hierarchy of ATP-consuming processes in mammalian cellsBiochemical Journal, 1995
- Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoidSteroids, 1994
- The effects of methylprednisolone on oxidative phosphorylation in Concanavalin‐A‐stimulated thymocytesEuropean Journal of Biochemistry, 1994
- Effects of methylprednisolone on the energy metabolism of quiescent and conA-stimulated thymocytes of the ratBioscience Reports, 1993
- In vitro effects of glucocorticoid on mitochondrial energy metabolismBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1991